NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle. - Wikidata - awgldk - TriplyDB

NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle.

NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle.

http://www.wikidata.org/entity/Q33985083

about

Preadministration of High-Dose Salicylates, Suppressors of NF- B Activation, May Increase the Chemosensitivity of Many Cancers: An Example of Proapoptotic Signal Modulation Therapy Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?The Janus-Faced Role of Antioxidants in Cancer Cachexia: New Insights on the Established Concepts Cancer cachexia: impact, mechanisms and emerging treatments Eicosapentaenoic acid and oxypurinol in the treatment of muscle wasting in a mouse model of cancer cachexia Metabolic and morphological alterations induced by proteolysis-inducing factor from Walker tumour-bearing rats in C2C12 myotubes.Tumor macroenvironment and metabolism.Signaling pathways initiated by beta-hydroxy-beta-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli.Attenuation of muscle atrophy in a murine model of cachexia by inhibition of the dsRNA-dependent protein kinase Pancreatic cancer cachexia: a review of mechanisms and therapeutics.Dietary exercise as a novel strategy for the prevention and treatment of metabolic syndrome: effects on skeletal muscle function.Expression of NF-kappaB and IkappaB proteins in skeletal muscle of gastric cancer patients.Cancer cachexia update in head and neck cancer: Pathophysiology and treatment.Long-chain omega-3 polyunsaturated fatty acids may be beneficial for reducing obesity-a review.The survival-promoting peptide Y-P30 enhances binding of pleiotrophin to syndecan-2 and -3 and supports its neuritogenic activity Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass.Review article: anorexia and cachexia in gastrointestinal cancer.Cancer cachexia and anabolic interventions: a case report.Toward a core nutraceutical program for cancer management.Increased expression of phosphorylated forms of RNA-dependent protein kinase and eukaryotic initiation factor 2alpha may signal skeletal muscle atrophy in weight-losing cancer patients Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo Roles and potential therapeutic targets of the ubiquitin proteasome system in muscle wasting.Found in transcription: gene expression and other novel blood biomarkers for the early detection of breast cancer.Update on emerging drugs for cancer cachexia.Candidate mechanisms underlying effects of contractile activity on muscle morphology and energetics in cancer cachexia.Mechanisms underlying the anti-wasting effect of L-carnitine supplementation under pathologic conditions: evidence from experimental and clinical studies.Helpful or harmful? Potential effects of exercise on select inflammatory conditions.Tumor inoculation site affects the development of cancer cachexia and muscle wasting.Effects of conjugated linoleic acid on myogenic and inflammatory responses in a human primary muscle and tumor coculture model.Diabetes-induced atrophy is associated with a muscle-specific alteration in NF-kappaB activation and expression Protein and Amino Acid Supplementation Does Not Alter Proteolytic Gene Expression following Immobilization.The AP-1/CJUN signaling cascade is involved in muscle differentiation: implications in muscle wasting during cancer cachexia.Oxidative stress, NF-κB and the ubiquitin proteasomal pathway in the pathology of calpainopathy.Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-alpha and angiotensin II by beta-hydroxy-beta-methylbutyrate.Metabolic Changes During Cancer Cachexia Pathogenesis.Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia.

P2860

Q22299231-7B65DAB1-1894-4287-AF46-EFC46489D3AD Q28068034-4D892100-B07B-4C24-BCB0-C7B22CD83BE9 Q28078802-C2F77591-54AC-468D-858B-1A2C0E56A1E3 Q28384479-83AA4582-1845-4283-8B7F-8AA3B26B052F Q28483912-3605396B-0C58-4AA8-B357-1A4B9075638B Q33316844-072D799C-095A-4993-B095-A2EE6425C71B Q33574461-005A3E83-9EAC-4521-932D-28E0B02FDEE4 Q34004957-6B62CAC7-18F5-4F00-A5F3-1F43868E4C69 Q34578128-0435CFB9-3C24-401B-A431-830D46898DB2 Q34660312-1E8B6FC7-9135-43D8-A85A-29E0FA9F6156 Q35104909-21ED2486-2F31-4046-A975-67D9E37DAB20 Q35111740-8A568745-FC94-468E-8316-C27B2E3A9441 Q35122201-6F36414D-A854-4CBD-BE57-9142862FCBC1 Q35670863-69B26CD1-6DB1-4571-AF47-3651AFD6F7FB Q35676748-EC8B6E45-28F5-447F-886A-C02166B8D04A Q36028202-63D0279B-B064-4E50-90EB-99F2EBE168C9 Q36266402-0741982F-FD71-48DD-A101-534B4FFC46F1 Q36421059-452629E9-34A2-49F0-B24E-368849111681 Q36473648-4D28B594-63D8-4CF7-AAFA-A2ADE41700AB Q36614674-50111E6A-4FBF-4A4B-8A50-5290CC00033F Q36756845-9DD742E1-A6E4-4094-9889-5C4972135FCB Q37019253-FE8A35FC-A008-41FC-9D15-18F3FD21D71D Q37577925-4F83E491-D164-4763-8537-EAF91BE5CB0E Q37622253-CE94E146-109B-45D5-ABFB-4AB7F8B30DDD Q37924325-E6CFD925-CC5C-4B95-9670-208D055E56C0 Q38090981-B9E7ADAD-3D16-40B4-8DF1-8E8ED2645478 Q38162669-88BD5E47-D287-40F7-9453-559BADD0E940 Q38870440-BB15CD9B-13DF-4F4A-A385-9335C70FF456 Q39786064-A8E11766-3F85-4719-8544-2A9C8D20F156 Q41809945-BCFE30AA-F9E6-4D07-9BB6-D171E8EA4607 Q41898403-C49A115F-5877-408F-9E31-0D3467F529D6 Q45855217-EDD167DD-EE89-4269-BA64-115AF30ED2F8 Q46262861-88B3E3A7-866D-448C-8B7F-9243A1DB294B Q46327161-B9C7407B-C873-45F1-9383-95371B3C4CDC Q49544329-A9543656-7CB4-4392-93A0-B57BA29EC3D0 Q55512132-0C772147-69C9-42BE-A8E6-91DAE73625B1

P2860

NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle.

http://www.wikidata.org/entity/Q33985083

description

2005 nî lūn-bûn

@nan

2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

NF-kappaB mediates proteolysis ...... ome system in skeletal muscle.

@ast

NF-kappaB mediates proteolysis ...... ome system in skeletal muscle.

@en

type

label

NF-kappaB mediates proteolysis ...... ome system in skeletal muscle.

@ast

NF-kappaB mediates proteolysis ...... ome system in skeletal muscle.

@en

prefLabel

NF-kappaB mediates proteolysis ...... ome system in skeletal muscle.

@ast

NF-kappaB mediates proteolysis ...... ome system in skeletal muscle.

@en

P1433

Q33985083-35A6061F-6E78-48F3-96FC-F5B781E1347C

P1476

Q33985083-3A76C13D-0AC3-47E4-B9A6-709235CB2032

P2093

Q33985083-97C21D57-340C-46E3-B2E0-C7200B79B044

Q33985083-D5D974CE-B97A-4BDA-B9B3-87D9AE5FAD73

P2860

Q33985083-0940684C-52E7-4F4D-9AC0-6DD51F2BBF20

Q33985083-1A39CEDE-B834-49A9-A8C6-47A772B8EBF6

Q33985083-1E99FC4A-D62B-4E4E-8812-29A5AE195078

Q33985083-2280BA5E-83B3-4785-A4D0-BFDF147465BB

Q33985083-27DE337F-C555-48E6-8EC7-81DFA493A80D

Q33985083-29D05A79-E420-4E91-8C1F-C061AF210FFE

Q33985083-38676824-6940-411D-B7D4-1A6C0AF197A2

Q33985083-4322E053-6B0C-4225-88F1-2BB8785EDA3A

Q33985083-44716C3C-4323-4007-A1A3-03A7AF37EBC9

Q33985083-481E04C1-E921-452C-BC71-70B1F6C81DBE

P2888

Q33985083-42CF44B8-E16E-4B76-9D24-7CFB9D5AC6AF

P304

Q33985083-574D19BC-3CE2-4EA0-BC6B-EAE4E5D90F4A

P31

Q33985083-ED39CA7E-2C4A-4253-9ADF-59DB469A2B10

P356

Q33985083-0143CED6-34DF-41F1-AEED-8D3C3928E0FE

P407

Q33985083-6E34EB76-7862-45D2-A0BC-F05D06415B0F

P433

Q33985083-47A752A9-C3C7-42D3-8F5C-281A8F80DD31

P478

Q33985083-415702D4-E400-4CFF-9734-890BAB534DB0

P577

Q33985083-9528FAD7-E370-412A-9B37-3A53BD559DAE

P5875

Q33985083-6E2A5D88-3727-4687-BD65-984CBAC077D7

P6179

Q33985083-A564A861-3E43-4A6D-8965-C74DD94FB616

P698

Q33985083-62C3D912-D720-42D4-8D09-64CB18E14248

P921

Q33985083-17A578AF-2DF7-4964-B4E0-B3E1CF9376CD

Q33985083-F732B9EB-4C20-4B38-9E2A-C26319019284

P932

Q33985083-96F90AE4-A5A6-477C-8DC8-E82F00C6FF4E

P356

P1433

British Journal of Cancer

P1476

NF-kappaB mediates proteolysis ...... ome system in skeletal muscle.

@en

P2093

M J Tisdale

http://www.w3.org/2001/XMLSchema#string

S M Wyke

http://www.w3.org/2001/XMLSchema#string

P2860

Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation

The proteasome-dependent proteolytic system

Characterization of a cancer cachectic factor

Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF)

Nuclear factor kappa B-inducing kinase and Ikappa B kinase-alpha signal skeletal muscle cell differentiation

Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway

A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells

NF-kappaB in cancer: from innocent bystander to major culprit

The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation.

The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer.

P2888

P304

711-721

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6602402

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8019374

http://www.w3.org/2001/XMLSchema#string

P6179

1033396138

http://www.w3.org/2001/XMLSchema#string

P698

15714207

http://www.w3.org/2001/XMLSchema#string

P921

ubiquitin-proteasome system

P932

2361865

http://www.w3.org/2001/XMLSchema#string